Completed in 2021 in Cambridge, United Kingdom. Images by Hufton+Crow. AstraZeneca is establishing a new global research and development facility, named The Discovery Centre (DISC) in Cambridge, UK, on the Cambridge...
附件：Press_Release_-_AstraZeneca_unveils_The_Discovery_Centre_(DISC)_in_Cambridge.pdf 转载自：...
In 2022 AstraZeneca invested $9.5 billion in R&D which represents 21% of Total Revenue, in order to continue to discover and develop medicines which transform the lives of patients. The Company has three world class strategic R&D centres including The Discovery Centre (D...
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & ...
Pfizer/BioNtech, AstraZeneca, Moderna and Johnson&Johnson. The duration of the digital green certificate should be limited to the end of the COVID-19 pandemic, the EU source said, adding that tests and quarantine will continue to be the enablers of free movement. Thus, vaccination does not ...
A group of pharma companies – Amgen, AstraZeneca and GlaxoSmithKline – have partnered with the UK government’s Equalities Office and Women’s Business Council to support small businesses in science, technology, engineering and maths (STEM) to offer a more gender-balanced work environment. ...
In the case of OLP, during AstraZeneca’s 2014 Phase I trial, the oral PARPi OLP and intravenous (IV) pegylated liposomal doxorubicin (PLD) combination elicited either a complete or partial response in only 25% of platinum resistant patients as opposed to the observed 71% for platinum ...
We used the index SNPs from our discovery GWAS and the effect estimates from the maternal nontransmitted alleles as genetic instruments in a two-sample Mendelian randomization analysis (Fig. 4b and Supplementary Fig. 15) on the maternal-only effects on birth weight (derived using a weighted linea...
Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK Rory Stark & Marta Grzelak Precision Medicine, Oncology R&D, AstraZeneca, Cambridge, UK James Hadfield Contributions J.H., R.S. and M.G. researched the literature. J.H. and R.S. discussed th...
Dr Mezquita reported performing lectures and educational activities for Bristol Myers Squibb, AstraZeneca, Roche, Takeda, Janssen, and MSD; serving as a consultant for Roche, Takeda, and Janssen; receiving grants from Amgen, Stilla, Inivata, and AstraZeneca; and receiving funds for travel, ...